Bio­gen's full Ph2 da­ta for IgA nephropa­thy drug; Sanofi in­vests in obe­si­ty biotech

7 months ago
News Briefing

Ab­b­Vie makes $1.4B ac­qui­si­tion of Alzheimer's biotech

7 months ago
Startups
Deals

HOPO Ther­a­peu­tics wins up to $226M BAR­DA con­tract for heavy met­al poi­son­ing re­search

7 months ago
R&D

Synaf­fix, in­dus­try's ADC part­ner of choice, spins out a start­up pipeline

7 months ago
Financing
Startups

For­mer Seagen CEO David Ep­stein to lead new biotech with VEGF bi­func­tion­al an­ti­body

7 months ago
Startups
R&D

Fog­Phar­ma re­brands as Para­bilis Med­i­cines, as CEO Math­ai Mam­men high­lights next drugs

7 months ago
Startups
R&D

No­var­tis pays Monte Rosa $150M for Phase 1 drug in lat­est en­dorse­ment of mol­e­c­u­lar glues

7 months ago
Deals

Lat­est sal­vo in Pfiz­er ac­tivist fight; John Car­rol­l's Q3 biotech roundup; In­tel­lia un­veils CRISPR re­sults; and more

7 months ago
Weekly

Rev­o­lu­tion Med­i­cines breaks ground in chal­leng­ing pan­cre­at­ic can­cer with two RAS drugs

7 months ago
R&D

Hun­gary's Olivér Várhe­lyi read­ies to be EU health com­mis­sion­er, pledg­ing ma­jor phar­ma sup­port

7 months ago
Pharma
Law

House Re­pub­li­cans push for more trans­paren­cy on gov­ern­ment-fund­ed tri­al da­ta

7 months ago
Pharma
FDA+

Iterum wins ap­proval for new oral an­tibi­ot­ic for UTIs. Now it wants a part­ner

7 months ago
Pharma
FDA+

Telix's new ra­dio­phar­ma spin­out banks on one tri­al for suc­cess, CEO says

7 months ago
Startups
Manufacturing

Post-Hoc: No­vo’s obe­si­ty en­e­mies

7 months ago
Editor's note
Pharma

Tyra's stock dips as it gives first look in chal­lenge to J&J’s blad­der can­cer drug Balver­sa

7 months ago
R&D

Lyell Im­munophar­ma to ac­quire Imm­PACT Bio, cut top pro­grams

7 months ago
Deals
Cell/Gene Tx

Bris­tol My­ers, Ideaya tout da­ta in sol­id tu­mors with cer­tain ge­net­ic mu­ta­tions

7 months ago
R&D

En­Gene’s $60M PIPE; Ab­b­Vie to de­vel­op neu­ropsy­chi­atric drugs with Gedeon Richter

7 months ago
News Briefing

Elu­ci­da On­col­o­gy, seek­ing foothold in AD­Cs, shut­ters due to 'lack of fund­ing'

7 months ago
People
Startups

Septer­na bags $288M up­sized IPO for GPCR drugs

7 months ago
Financing
Startups

Chi­nook alums re­unite fol­low­ing ex­it to No­var­tis; The first board ap­point­ment for Re­cur­sion’s Chris Gib­son

7 months ago
Peer Review

GSK to spend $800M to build two vac­cine fac­to­ries in the US

7 months ago
Manufacturing

Sanofi re­ports sales jump for Bey­for­tus as RSV an­ti­body chal­lenger from Mer­ck nears

7 months ago
Pharma

Sanofi backs fi­bro­sis biotech Agomab as it rais­es $89M Se­ries D

7 months ago
Financing
Startups
First page Previous page 85868788899091 Next page Last page
A service from the Financial Times